Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
san francisco blog main
san francisco top stories
3
×
startups
boston blog main
boston top stories
boulder/denver blog main
drug development
national top stories
new york top stories
vc
23andme
accent therapeutics
aducanumab
alphabet
alzheimer's disease
amblyotech
american academy of ophthalmology
analytics
asklepios biopharmaceutical
azacitidine
beta-thalassemia
big data
bioeurope
biogen
biomarin pharmaceutical
biomatics capital
boston
boulder/denver top stories
brainvectis
brook byers
c. greg guyer
cancer
cara therapeutics
dacogen
deals
decitabine
What
developing
3
×
new
3
×
drugs
medicines
activity
adds
aims
analyzes
approach
approvals
based
bio
biogen
biotech
called
ceo
clamped
company
covid
data
debuts
delays
devices
economic
electronic
epigenetic
epigenetics
fast
fda
field
financing
flagship’s
gv
health
including
insights
ipo
isn’t
kapoor
lands
Language
unset
Current search:
developing
×
new
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO